Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary

George D. Malkasian, L. Joseph Melton, Peter C. O'Brien, Mark H. Greene

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Overall survival in 1938 women with epithelial ovarian cancer receiving primary treatment at Mayo Clinic was 35% at 5 years, 28% at 10 years, and 15% at 25 years. For most histologic cell types, observed differences in survival were more apparent than real since the behavior of different cell types was similar when compared stage for stage and grade for grade. Mucinous cystadenocarcinomas tended to be low grade and low stage, while serous cystadenocarcinomas tended to be high grade and high stage. For Stage I disease, factors other than cell type seemed to be more important in determining survival; specifically. Stage IA1 patients did significantly better than all other Stage I patients. In Stage III disease, the amount of residual tumor made a significant difference in survival for all grades. In Stage IV disease, the amount of residual made a highly significant difference in survival for grade 1 disease.

Original languageEnglish (US)
Pages (from-to)274-284
Number of pages11
JournalAmerican Journal of Obstetrics and Gynecology
Volume149
Issue number3
DOIs
StatePublished - Jun 1 1984

Fingerprint

Ovary
Survival
Neoplasms
Serous Cystadenocarcinoma
Mucinous Cystadenocarcinoma
Residual Neoplasm
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. / Malkasian, George D.; Melton, L. Joseph; O'Brien, Peter C.; Greene, Mark H.

In: American Journal of Obstetrics and Gynecology, Vol. 149, No. 3, 01.06.1984, p. 274-284.

Research output: Contribution to journalArticle

Malkasian, George D. ; Melton, L. Joseph ; O'Brien, Peter C. ; Greene, Mark H. / Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. In: American Journal of Obstetrics and Gynecology. 1984 ; Vol. 149, No. 3. pp. 274-284.
@article{4ea267bad33449e4949bbeade7226e14,
title = "Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary",
abstract = "Overall survival in 1938 women with epithelial ovarian cancer receiving primary treatment at Mayo Clinic was 35{\%} at 5 years, 28{\%} at 10 years, and 15{\%} at 25 years. For most histologic cell types, observed differences in survival were more apparent than real since the behavior of different cell types was similar when compared stage for stage and grade for grade. Mucinous cystadenocarcinomas tended to be low grade and low stage, while serous cystadenocarcinomas tended to be high grade and high stage. For Stage I disease, factors other than cell type seemed to be more important in determining survival; specifically. Stage IA1 patients did significantly better than all other Stage I patients. In Stage III disease, the amount of residual tumor made a significant difference in survival for all grades. In Stage IV disease, the amount of residual made a highly significant difference in survival for grade 1 disease.",
author = "Malkasian, {George D.} and Melton, {L. Joseph} and O'Brien, {Peter C.} and Greene, {Mark H.}",
year = "1984",
month = "6",
day = "1",
doi = "10.1016/0002-9378(84)90227-8",
language = "English (US)",
volume = "149",
pages = "274--284",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary

AU - Malkasian, George D.

AU - Melton, L. Joseph

AU - O'Brien, Peter C.

AU - Greene, Mark H.

PY - 1984/6/1

Y1 - 1984/6/1

N2 - Overall survival in 1938 women with epithelial ovarian cancer receiving primary treatment at Mayo Clinic was 35% at 5 years, 28% at 10 years, and 15% at 25 years. For most histologic cell types, observed differences in survival were more apparent than real since the behavior of different cell types was similar when compared stage for stage and grade for grade. Mucinous cystadenocarcinomas tended to be low grade and low stage, while serous cystadenocarcinomas tended to be high grade and high stage. For Stage I disease, factors other than cell type seemed to be more important in determining survival; specifically. Stage IA1 patients did significantly better than all other Stage I patients. In Stage III disease, the amount of residual tumor made a significant difference in survival for all grades. In Stage IV disease, the amount of residual made a highly significant difference in survival for grade 1 disease.

AB - Overall survival in 1938 women with epithelial ovarian cancer receiving primary treatment at Mayo Clinic was 35% at 5 years, 28% at 10 years, and 15% at 25 years. For most histologic cell types, observed differences in survival were more apparent than real since the behavior of different cell types was similar when compared stage for stage and grade for grade. Mucinous cystadenocarcinomas tended to be low grade and low stage, while serous cystadenocarcinomas tended to be high grade and high stage. For Stage I disease, factors other than cell type seemed to be more important in determining survival; specifically. Stage IA1 patients did significantly better than all other Stage I patients. In Stage III disease, the amount of residual tumor made a significant difference in survival for all grades. In Stage IV disease, the amount of residual made a highly significant difference in survival for grade 1 disease.

UR - http://www.scopus.com/inward/record.url?scp=0021269124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021269124&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(84)90227-8

DO - 10.1016/0002-9378(84)90227-8

M3 - Article

VL - 149

SP - 274

EP - 284

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -